behavioral testing strategies in a localized animal model of multiple sclerosis
TRANSCRIPT
www.elsevier.com/locate/jneuroim
Journal of Neuroimmunology 153 (2004) 158–170
Behavioral testing strategies in a localized
animal model of multiple sclerosis
Bigna S. Buddeberg, Martin Kerschensteiner 1, Doron Merkler2,Christine Stadelmann2, Martin E. Schwab*
Brain Research Institute, University of Zurich and Department Biology Swiss Federal Institute of Technology,
Winterthurerstrasse 190, CH-8057, Zurich, Switzerland
Received 16 January 2004; received in revised form 26 April 2004; accepted 21 May 2004
Abstract
To assess neurological impairments quantitatively in an animal model of multiple sclerosis (MS), we have used a targeted model of
experimental autoimmune encephalomyelitis (EAE), which leads to the formation of anatomically defined lesions in the spinal cord. Deficits
in the hindlimb locomotion are therefore well defined and highly reproducible, in contrast to the situation in generalized EAE with
disseminated lesions. Behavioral tests for hindlimb sensorimotor functions, originally established for traumatic spinal cord injury, revealed
temporary or persistent deficits in open field locomotion, the grid walk, the narrow beam and the measurement of the foot exorotation angle.
Such refined behavioral testing in EAE will be crucial for the analysis of new therapeutic approaches for MS that seek to improve or prevent
neurological impairment.
D 2004 Elsevier B.V. All rights reserved.
Keywords: EAE; Multiple sclerosis; Behavior; Locomotion
1. Introduction
Multiple sclerosis (MS) is a major inflammatory, demy-
elinating disease of the central nervous system (CNS) that
leads to severe neurological disabilities (Noseworthy et al.,
2000). Similar disabilities can be mimicked in experimental
autoimmune encephalomyelitis (EAE), the most commonly
used animal model to study MS in rats and mice. The
classical EAE model is characterized by disseminated
lesions which give rise to a high variability in disease
course and behavioral outcome. Behavioral symptoms in
EAE animals may be related to a brainstem lesion or to a
lesion located in the spinal cord or the cerebellum. In
addition, EAE animals often have multiple lesions adding
even more to the complexity of the observed disease course.
Therefore, sensitive behavioral testing is hard to carry out in
a classical EAE model and the disease course of animals
0165-5728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.jneuroim.2004.05.006
* Corresponding author. Tel.: +41-1-635-3330; fax: +41-1-635-3303.
E-mail address: [email protected] (M.E. Schwab).1 Department of Anatomy and Neurobiology, Washington University
School of Medicine, St. Louis, USA.2 Institute of Neuropathology, University of Gottingen, Germany.
with such diverse symptoms might be difficult to compare.
This is the reason why the only behavioral analysis carried
out in classical EAE so far is an assessment of general over-
ground locomotion with a rough five-step scoring system
(Meyer et al., 2001).
In contrast, the field of traumatic spinal cord injury has
put much effort on the elaboration of behavioral tests
allowing sensitive and specific assessment of locomotor
function (Kunkel-Bagden et al., 1993; Metz et al., 2000;
Muir and Webb, 2000). Hindlimb movements are dependent
on the integrity of central pattern-generating networks
situated in the lumbar spinal cord and reflex pathways under
the control of descending motor tracts from the brainstem
and cortex (Pearson, 1976; Raineteau and Schwab, 2001). A
well-chosen combination of tests can therefore reveal the
extent of damage to these different tract systems after spinal
cord injury.
For example, the BBB open field locomotion score
(Basso et al., 1995) measures general over-ground locomo-
tion, which is influenced by various descending tract sys-
tems as well as intraspinal networks. The footprint analysis
visualizes the pattern of hindlimb locomotion with special
regard to the foot rotation angle, toe spreading, stride length,
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170 159
and base of support (De Medinaceli et al., 1982; Kunkel-
Bagden et al., 1993; Metz et al., 2000). Integrity of supra-
spinal input to spinal cord circuits can be measured by the
grid walk test (Kunkel-Bagden et al., 1993; Merkler et al.,
2001; Metz et al., 2000). This paradigm requires fine
sensorimotor control and precise foot placing, and therefore
relies partly on an intact corticospinal tract (CST). The same
has been described for the narrow beam test in which
animals are required to cross elevated beams of varying
width and shape (Hicks and D’Amato, 1975; Metz et al.,
2000). However, these tests are not well applicable in
conventional EAE models due to the disseminated nature
of the inflammatory lesions and consequently the high
variability of the functional impairment.
Recently, we succeeded in establishing a new, targeted
EAE model (Kerschensteiner et al., 2004). Rather than
mimicking the disseminated disease course of MS, this
model localizes the disease to one single inflammatory
lesion at a defined location of the spinal cord. In the present
study, we targeted the inflammatory lesion to the dorsal
thoracic spinal cord at a level of T8 resulting in an affection
of the CST and other dorsal and lateral tract systems.
Therefore, the animals exhibit predictable and comparable
deficits.
The aim of the present study is to expand the initial
observations, to evaluate systematically, which of the estab-
lished tests used in the traumatic spinal cord injury field
would be transferable to the targeted EAE model, and how
these tests correlate with the standard EAE clinical score. A
quantitative and precise assessment of these functional
deficits is of crucial importance for the evaluation of
therapeutic strategies.
2. Materials and methods
2.1. Animals
A total of 51 adult female Lewis rats (180–220 g)
obtained from Harlan (Horst, The Netherlands) were used.
45 animals underwent the sensitization procedure and spinal
cord injection and 6 animals were used as controls and did
not receive any sensitization or injection. The rats were
housed in groups of five or six under a 12:12-h light/dark
cycle with food and water ad libitum. All experiments were
approved by the Veterinary Department of the Canton of
Zurich.
2.2. Induction of the localized EAE lesion
Rats were anaesthetized by inhalation anaesthesia. In-
duction of localized EAE was performed as previously
described (Kerschensteiner et al., 2004). Briefly, recombi-
nant myelin oligodendrocyte glycoprotein (MOG; 10–25
Ag diluted in saline) was emulsified in incomplete Freund’s
adjuvant (IFA; Sigma) and a total volume of 100 Al was
injected subcutaneously into the base of the tail. This
sensitization protocol leads to the induction of an anti-
MOG immune response without the development of clinical
disease (Kerschensteiner et al., 2004). About 18–22 days
after sensitization, the development of a localized EAE
lesion at a predetermined location of the spinal cord was
induced by the injection of cytokines. Sensitized rats were
anaesthetized with a combination of Dormicum [midazo-
lam, 0.6 mg/100-g body weight intraperitoneally (i.p.);
Roche; Basel, Switzerland] and Hypnorm (fentanyl, 0.02
mg/100-g body weight; Janssen-Cilag; Beerse, Belgium).
Two microliters of a cytokine solution containing 250 ng of
recombinant rat TNF-a (R&D Systems; Abingdon, UK) and
150 U of recombinant rat IFN-g (Pepro Tech; London, UK)
dissolved in PBS were injected into the spinal cord at the
thoracic level 8, with a minimal invasive stereotactic tech-
nique as previously described (Kerschensteiner et al., 2004).
2.3. Histology
Histological analysis of the EAE lesions were performed
in some rats after the behavioral analysis was concluded 28
days postinjection. For this purpose, rats were killed by a
pentobarbital overdose (50 mg/100 g) and perfused trans-
cardially with Ringer solution containing 100000 IU/l hep-
arin and 0.25% NaNO2, followed by 4% paraformaldehyd
in 0.1 M phosphate buffer with 5% sucrose. The spinal
cords were dissected and postfixed over night. After im-
mersion for 4–6 days in a 30% sucrose solution, the
segments of the spinal cord containing the EAE lesion were
cut on a vibratom in serial 50-Am cross-sections. The
sections were mounted, air dried, stained with cresyl violet
and were cover-slipped with Eukitt (Kindler; Freiburg,
Germany). Lesions were analysed with a light microscope
(Zeiss, Germany).
In addition, histological evaluation was performed on 1-
Am sections of representative spinal cords as previously
described (Kerschensteiner et al., 2004). Sections were
stained with Luxol fast blue and Bielschowsky silver
impregnation to assess demyelination and axonal pathology,
respectively. The extent of macrophage influx was visual-
ized by immunohistochemistry with antibodies against
macrophages/activated microglia (clone ED1, Serotec; Ox-
ford, UK). Detection of amyloid precursor protein (APP,
clone 22C11; Chemicon, USA) as a marker for acute axonal
damage was performed on adjacent sections.
2.4. Behavioral analysis
The disease course of all animals was evaluated with the
classical EAE-scoring scale (Kerschensteiner et al., 2004;
Meyer et al., 2001). With subgroups of the animals, we
performed a number of tests specifically designed to assess
hindlimb motor function. Performed tests can be divided
into two major groups: basic locomotor tests and tests to
assess specific aspects of locomotion. In addition, we
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170160
addressed the open field exploration of the animals with an
activity measuring system in order to determine the impact
of the disease course on the spontaneous locomotor activity.
If not mentioned differently, tests were performed before
induction of the localized lesion (baseline evaluation) and
then at 3, 7, 14, 21 and 28 days postlesion induction (D3,
D7, D14, D21 and D28).
2.4.1. Spontaneous locomotor activity
To measure the spontaneous open field activity and
inquisitiveness, the activity measuring system TSE Acti-
Mot/MoTil was used. The rat is placed in a 48� 48-cm box
with four pairs of light–barrier strips. The light–barrier
strips are arranged at right angles to each other. Two pairs
are installed at the bottom of the box to determine the X and
Y coordinates of the animal during normal locomotion. The
other two pairs of light–barrier strips are arranged at a
higher lever so that the rat only interferes with the light
beams when rearing. A few days before the first testing
session, the animals were placed into the activity box for a
period of 10 min to make them familiar with the testing
situation. At the beginning of every testing session, we gave
the animals 1 min for habituation before the pattern of
movement was recorded during 29 min. We evaluated the
following parameters: total distance which the animal cov-
ered in the time given, number of rearings and number of
rotations.
2.4.2. Basic locomotor tests
Basic locomotor tests were carried out to measure the
recovery of the general hindlimb locomotor performance.
2.4.2.1. EAE clinical score. For the evaluation of the
disease course, all rats were examined daily from the
sensitization on and up to 28 days after the cytokine
injection. An adapted EAE-scoring scale was used (Ker-
schensteiner et al., 2004; Meyer et al., 2001):
1. Score = 0, no clinical disease;
2. Score = 0.5, partial tail weakness or slight loss of
muscle tone;
3. Score = 1.0, tail weakness;
4. Score = 1.5, slightly clumsy gait;
5. Score = 2.0, hindlimb paresis;
6. Score = 2.5, marked hindlimb paresis and partial
dragging of the hindlimbs;
7. Score = 3, hindlimb paralysis;
8. Score = 3.5, hindlimb paralysis and forelimb paresis;
9. Score = 4.0, complete paralysis (tetraplegy);
10. Score = 5.0: moribund or dead.
Due to the localized nature of the lesion, the animals did not
score any higher than 3.
2.4.2.2. BBB open field locomotion score. The BBB open
field locomotion score was described by Basso et al. (1995)
to measure recovery of hindlimb movements after spinal
cord contusion injury in rats during free open field locomo-
tion. For examination, rats are placed one by one in a
70� 70-cm transparent Plexiglas box with walls of 30-cm
and a pasteboard-covered nonslippery floor. Two examiners
observe each rat during a period of 3–5 min. The nonlinear
scoring scale (score 0 to 21) covers a broad range of
parameters assessing a sequence of locomotor recovery,
starting with no spontaneous movement of the hindlimbs
up to plantar stepping, weight support, forelimb–hindlimb
coordination and trunk stability. A score of 21 indicates
unimpaired locomotion as observed in unlesioned rats. We
used a slightly modified version of the BBB score, as
previously described (Metz et al., 2000). When the sequence
of recovering motor features was not the same as described
in the original score, points for the single features were
added independently.
2.4.3. Tests for specific aspects of locomotion
2.4.3.1. Grid walk. Deficits in descending motor control
were examined by assessing the ability to cross a 1-m-long
runway with irregularly spaced bars (1-4 cm) elevated 1 m
above the ground as previously described (Merkler et al.,
2001; Metz et al., 2000; Metz and Whishaw, 2002). A
defined sector of 13–20 bars was chosen for analysis.
In order to cross the runway, accurate placement of the
limbs on the bars is required. Animals were trained for 5
days before baseline evaluation. For baseline and postoper-
ative testing, each animal had to cross the runway at least
twice. Evaluation was done on video recordings of the trials.
A drop of the foot below the plane of the grid was
considered as a footfall. The total number of footfalls as
well as the total number of steps was counted and then the
percentage of footfalls per steps was calculated. Animals
which were not able to support their bodyweight with the
hindlimbs would make errors with every step and were thus
assigned 100% of footfalls.
2.4.3.2. Narrow beam. This paradigm was performed to
assess the ability of the animals to balance across a 1-m-
long wooden beam which was elevated 30 cm above the
ground. Animals were tested on three different beams: a
rectangular 2.3-cm-wide beam, a rectangular 1.2-cm-wide
beam and a round beam with a diameter of 1.5 cm. Thus, the
difficulty to balance across increased from beam to beam.
Animals were trained for 5 days before baseline evaluation.
For baseline and postoperative testing, animals had to cross
each beam three times and were then evaluated by a scoring
system previously described (Metz et al., 2000). For tra-
versing each beam with full weight support and normal
plantar paw placing, a score of 2 was applied. If plantar
placing of the paw was only partly possible, the animal
scored 1.5. A score of 1 was given if the animal could
traverse the entire beam but without plantar placing of the
hind paws. When only half of the beam could be crossed, a
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170 161
score of 0.5 was assigned, and for complete inability to
cross the beam, a score of 0 was applied. For each beam, the
average score was calculated. Average scores of all three
beams were then added up so that a maximum of 6 points
could be reached.
2.4.3.3. Footprint analysis. Footprint analysis was modi-
fied from Metz et al. (2000) and De Medinaceli et al.
(1982). The animal’s hind paws were inked and footprints
were made while the animal walked along a 1-m-long and 7-
cm-wide runway with a paper-covered floor. The runway
ensured that the animal was walking along a straight line. A
sequence of at least six consecutive steps was chosen for
evaluation. For each time point, three measurements of the
angle of foot rotation, the base of support and the stride
length on the left and the right sides were taken. Then, the
average value for each parameter was calculated.
The base of support was determined as the distance
between the central pads of the hind paws. Stride length
was determined as the distance between the central pads of
two consecutive footprints on the same side. As a measure-
ment of the limb rotation, the angle between the lines
through the third digit and the central pad of each paw
was determined. In baseline testing, footprint analysis was
performed with all animals. After spinal cord injection,
footprint recording could be carried out only once the
animals were able to support the weight of their hind body
properly. Animals with incomplete weight support would
smear the fresh ink prints with their dragging body.
2.5. Statistical analysis
For ordinal-scaled tests (EAE and BBB scores and
narrow beam), data are presented as the median; first and
third quartiles are shown as well. The results of the interval-
scaled tests (activity parameters, grid walk and footprint
parameters) are presented as the meanF standard error
(S.E.M.). The correlations between the EAE score and other
behavioral tests were calculated with the Spearman’s rank
test (Spearman’s, r). Analyses of variances (ANOVAs) with
repeated measurements and following contrast (repeated)
were carried out using SPSS for Windows to calculate the
significance between measurements of individual time
points. P values of V 0.05 were considered significant;
values of V 0.01 were considered highly significant.
3. Results
3.1. Histology
In all the animals examined, a single, well-circumscribed
lesion site was observed in the dorsal half of the spinal cord.
The lesions varied in size. As shown earlier, the lesion
volume correlates significantly with the maximal behavioral
deficits measured with several locomotor tasks (Kerschen-
steiner et al., 2004). In this study, we show representative
lesions of one animal with a severe disease course (maximal
EAE score: 2.5) and one animal with a milder disease course
(maximal EAE score: 1.5) at D28. Animals with a higher
maximal deficit have a larger extent of myelin destruction
(Fig. 1a,b; LFB/PAS staining) and macrophage infiltration
(Fig. 1c,d; ED1 staining). In addition, Bielschowsky staining
(Fig. 1e–h) and APP staining (Fig. 1i,j) demonstrate a greater
loss of axons including CSTaxons in the animal with a severe
clinical deficit. These results are in full agreement with the
more extensive histological description in this lesion model
given in our previous study (Kerschensteiner et al., 2004).
3.2. Behavioral analysis
3.2.1. Spontaneous locomotor activity
It has been shown that classical EAE leads to a decrease
in many aspects of general activity such as food intake and
exploration, a phenomenon commonly referred to as the
EAE behavioral syndrome (Pollak et al., 2000, 2003a,b). To
rule out the possibility that the general locomotor activity of
the rats with targeted EAE decreases at early stages of
disease, and therefore would interfere with the locomotor
performance in the individual tests, we studied the sponta-
neous activity performance of nine animals with localized
EAE, in comparison to the performance of six control
animals which had received no sensitization or surgical
treatment. We recorded three different parameters: the total
distance which the animals covered in the given time, the
number of rearings and the number of rotations as shown in
Fig. 2. The variability in between individual testing sessions
was substantial in both the control and the EAE group. The
performance in the parameters total distance and number of
rearings did not show a significant difference between the
EAE and the control animals after the onset of the disease.
Only the number of rearings was initially reduced but
recovered after D14 in EAE.
3.2.2. Basic locomotor tests
We have previously shown that substantial behavioral
impairments occur in rats which have undergone the sensi-
tization procedure as well as the cytokine injection into the
spinal cord. Sensitization alone followed by an injection of
PBS without cytokines does not lead to the formation of
large inflammatory lesions and is thus not expected to cause
a substantial change in the locomotor performance (Ker-
schensteiner et al., 2004). We therefore focused the current
study only on the behavioral assessment of animals, which
underwent both sensitization and cytokine injection.
By correlating the results from the different tests with the
classic EAE score, we addressed the question whether they
allow the quantification of additional locomotor properties.
3.2.2.1. EAE clinical score. All animals (n = 45) were
scored daily according to an adapted version of the EAE
clinical score as described under Materials and Methods.
Fig. 1. Representative thoracic spinal cord cross sections of an animal with a mild (maximal EAE score 1.5; a, c, e, g and i) and an animal with a more severe
disease course (maximal EAE score 2.5; b, d, f, h and j) at D28. The animal with a higher maximal deficit displays a more extended area of demyelination (b;
LFB/PAS staining) including the region of the dorsal CST and infiltration of ED1 positive macrophages is more widespread (d). Bielschowsky staining (e– f)
shows the marked reduction of axons in the dorsal funiculus of both animals, including the dorsal region of the CST (g–h). In contrast to the animal with a
milder disease course (i), acute axonal damage reflected by APP-positive axonal spheroids is found in the region of CST (j) in the animal with more severe
EAE. Arrowheads in panel j indicate APP-positive axons.
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170162
Fig. 2. Time course of three different parameters of locomotor activity for nine EAE (n) and six control (w ) animals. (a) Overall distance covered in the given
time (29 minutes), (b) number of rearings and the (c) number of rotations. Data are shown as the meanF S.E.M. Although the EAE rats score slightly lower,
variability in both groups is high and no significant change in activity, which could be attributed to the disease, as was observed except at D3 for rearings. (11)
indicates that the difference was highly significant ( p< 0.01).
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170 163
Scoring started at the time point of sensitization and was
performed up to 28 days after cytokine injection. Results are
shown in Fig. 3a. In the period after sensitization but before
cytokine injection, the animals showed no signs of clinical
disease. The first signs of clinical disease usually became
Fig. 3. Tests, which assess general aspects of locomotion: EAE score (a–b) and
animals) starting at the time of sensitization up to 28 days postcytokine injection. T
animal with a high (w ) and an animal with a low (.) EAE score at D3. (c) Time co
third quartile. Animals were tested once before cytokine injection (BL), once at the
injection (D28). (d) Correlation between the EAE and the BBB scores at D3 (r =
significant ( p< 0.05), it is indicated with 1; when it was highly significant ( p<
apparent on the first day after the cytokine injection. Three
days postinjection (D3), the animals normally reached their
maximal clinical score (median value, 2; first quartile, 2;
third quartile, 2.5) which they kept for about 1 week.
Afterwards, a slow recovery resulting in a consistent decline
BBB score (c–d). (a) Time course of the median of the EAE score (n= 45
hin lines indicate the first and the third median. (b) Typical time course of an
urse of the median BBB score of 18 animals. Thin lines indicate the first and
peak of disease (D3) and then on a weekly basis until 28 days after cytokine
� 0.79; p< 0.01). If the difference between two following time points was
0.01), it is indicated with 11.
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170164
of the clinical score was observed. At the end of the testing
period (D28), the majority of the animals had recovered
completely to a score of 0. From the 18 animals with an
initial EAE score of 2.5 or 3, 10 showed a remaining deficit
after 28 days, 8 animals had fully recovered. From the 27
animals with an initial score of 2 or less, 24 animals had
fully recovered after 28 days, whereas 3 animals showed a
remaining deficit. This indicates that the severity of the
initial disease course influences the long-term deficits.
Fig. 3b shows the typical disease courses of an animal
with a high and an animal with a low initial score.
3.2.2.2. BBB open field locomotion score. A more detailed
analysis of open field locomotion using the BBB score was
performed with 18 animals (Fig. 3c). At the baseline
evaluation, all animals obtained the maximum score of 21
points. At D3, the animals showed their maximal locomotor
deficit reflected by a median score of 12 (first quartile, 9.25;
third quartile, 13). A score of 12 corresponds to consistent
weight-supporting plantar steps and occasional forelimb–
hindlimb coordination. In the following days, the locomotor
performance substantially improved and reached a plateau at
D21, with a median of 19 (first quartile, 18; third quartile,
20). At this time point, animals showed consistent plantar
stepping and consistent forelimb–hindlimb coordination.
Some animals still revealed a slightly rotated foot position
at liftoff, whereas others had a parallel paw position all of
the time. Animals with a score below 8 (no weight support)
at D3 (n = 2) recovered only incompletely up to a BBB score
of 15 points, whereas in animals with an initial score of 8 or
more (n = 16), an almost full recovery (up to 19–21 points)
could be observed.
Seven animals did not follow the sequence of recovery
described in the BBB score and showed a ‘tail-up’ position
before they reached a score of 19. Therefore, an additional
point was given as described under Materials and Methods.
Recovery of both hindlimbs usually occurred in parallel.
Only in one animal, we were able to observe a difference in
the locomotor performance of the two hindlimbs at early
timepoints (D3 and D7). In this case, we scored the two
hindlimbs separately, and then assigned the animal the mean
of the two scores. Along with the locomotor recovery, the
difference between the limbs vanished, and at later time-
points, both limbs scored equally.
Table 1
Correlations between EAE score and different behavioral tests
D3 D7
BBB � 0.73265** � 0.67167**
Grid walk 0.54613** 0.61859**
Narrow beam � 0.81944** � 0.45384
Footprints: rotation � 0.07297
Footprints: base of support 0.46027
Footprints: stride length 0.13392
Correlations between the EAE score and the different behavioral tasks over the e
*p< 0.05.
**p< 0.01.
The BBB score revealed a significant correlation with the
EAE score over the entire time course (Table 1), indicating
that the BBB score measures similar aspects as the EAE
score. The correlation between the BBB and the EAE scores
at D3 [shown in Fig. 3d (r=� 0.733; p < 0.01)] illustrates that
every score point on the EAE scale covers a broad range of
score points on the BBB scale. The BBB score therefore
allows a more sensitive discrimination than the EAE score.
3.2.3. Tests for specific aspects of locomotion
3.2.3.1. Grid walk. This test requires that the animals are
able to control and place their hindlimbs precisely and
depends on supraspinal input partly mediated by the CST.
We tested a total number of 25 EAE animals. The results
are shown in Fig. 4a. During baseline measurements, the
animals crossed the grid with a mean error percentage of
5F 1%. At D3, the error percentage mounted to the max-
imum observed during the testing period (67F 7%) and
then declined rapidly. The most pronounced improvement
took place between D7 and D14. At D7, the animals made a
mean of 54F 8% mistakes and recovered to a mean of
19F 4% at D14. Further recovery after D14 was consider-
ably slower and less pronounced. At D21, the mean error
percentage reached 16F 5%, and at D28, the mean error
percentage was 16F 4%.
At D3, 10 animals and at D7, 6 animals were unable to
support their body weight with the hindlimbs. Therefore,
these animals were dragging themselves with the use of the
forelimbs only over the grid and fell with the hindlimbs into
every gap. They were therefore assigned an error percentage
of 100%. These animals tended to show a remaining deficit
in their grid walk performance at D28 compared to those 15
animals which showed weight support at early stages of the
disease. At later time points (D14, D21 and D28), all
animals were able to walk over the grid.
The correlation between the grid walk and the EAE score
at D3 is shown in Fig. 4b (r = 0.546; p < 0.01). The corre-
lation is highly significant over the entire time course (Table
1), indicating that the EAE score and the grid walk assess
similar locomotor mechanisms. As for the BBB score, each
point on the EAE scale covers a broad range of grid error
percentage, showing that the grid walk allows for a refine-
ment in behavioral assessment compared to the EAE score.
D14 D21 D28
� 0.34936 � 0.56684** � 0.49544*
0.52025** 0.61931** 0.80815**
� 0.44420 � 0.82297** � 0.76671**
0.39632 0.46841 � 0.39313
0.37963 0.30739 � 0.10808
� 0.2904 � 0.17650 � 0.63560
ntire time course shown as r-values.
Fig. 4. Behavioral paradigms which address specific aspects of locomotion: grid walk and narrow beam. All tests were performed once before the cytokine
injection (BL), once at the peak of the disease (D3) and then on a weekly basis until 28 days after cytokine injection (D28). (a) Time course of the grid walk
paradigm. The mean percentage of footfalls of 25 animals is shown with the S.E.M. Animals revealed maximum deficit at D3. The most pronounced recovery
could be observed within the first 2 weeks. (b) Correlation between the EAE score and the grid error percentage at D3 (r = 0.55; p< 0.01). (c) Time course of
the narrow beam performance of 18 animals presented as the median (thick line). Thin lines indicate the first and the third quartile. As seen for the grid walk,
the peak deficits were observed at D3, and the major recovery took place within the first 2 weeks. (d) Correlation between the EAE score and the narrow beam
score at D3 (r =� 0.82; p< 0.01). If the difference between two following time points was significant ( p< 0.05), it is indicated with 1; when it was highly
significant ( p< 0.01), it is indicated with 11.
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170 165
3.2.3.2. Narrow beam. With this test, we investigated the
ability of 18 animals to navigate across a 1-m-long beam of
varying width and shape. Like the grid walk, this test relies
on supraspinal input partly mediated by the CST.
The results are shown in Fig. 4c. At baseline testing, all
animals were able to cross all three beams with proper
plantar steps and less than one or two footfalls; thus, all of
them reached the maximum score of 6. At D3, the median
score was 3.34 (first quartile, 2.21; third quartile, 4.79). As
in the grid walk test, the most pronounced improvement
took place within the first 14 days. By D7, the median score
was 4.83 (first quartile, 2.79; third quartile, 5.42). By D14,
the median was 5.59 (first quartile, 4.63; third quartile,
5.96). In the following 2 weeks, the improvement slowed
down considerably. By D21, a median of 5.67 (first quartile,
5.25; third quartile, 5.83), and by D28, a median of 5.83
(first quartile, 5.71; third quartile, 6) was reached. At D28,
8 animals had fully recovered to a score of 6, whereas 10
animals still showed a remaining deficit.
The correlation between the narrow beam and the EAE
score over the entire time course is shown in Table 1. The
correlation between the narrow beam and the EAE score at
D3 is shown in Fig. 4d (r =� 0.819; p< 0.01). As for the BBB
score and the grid walk, the correlation is significant and each
score point in the EAE score covers a broad range of score
points in the narrow beam score showing the refinement in
behavioral analysis achieved with the narrow beam score.
3.2.3.3. Footprint analysis. Footprint analysis reflects
aspects of hindlimb balance (exorotation of feet, broad base
of support) and kinetics (stride length).
We analysed the footprints of 12 EAE animals. Only
animals with a good locomotor performance (complete
weight support) could be included in the analysis. At D3,
many animals did not show enough weight support to
deliver proper footprints. We therefore started footprint
measurements only at D7 and then carried them out once
a week as the other test paradigms.
Baseline evaluation revealed a mean foot exorotation
angle of 19.1F1.4j. After the lesion induction, the rotation
angle increased to a mean of 37.7F 2.4j at D7 and remained
at this increased level for the rest of the testing period (Fig.
5a). The base of support showed a baseline value of
1.7F 0.1 cm. It increased to a mean value of 2.0F 0.2 cm
at D7 and then dropped down to a subbaseline value of
1.4F 0.1 by D14 (Fig. 5b). The baseline value for the stride
length was 12.7F 0.3 cm. No significant alteration could be
observed after the cytokine injection (Fig. 5c).
As already mentioned before, we took three measure-
ments of every parameter at every time point and then
calculated the mean. Individual measurements of the base of
support showed a high variability, sometimes, exceeding
more than 100%.
None of the footprint parameters investigated correlated
with the EAE score (Table 1) indicating that footprint
Fig. 5. (a–c) Result of three different parameters obtained from the analysis
of footprints. Measurements were taken once before cytokine injection (BL)
and on a weekly basis after the cytokine injection starting at D7. Results are
shown as the meanF S.E.M. (a) Angle of exorotation of the feet increased
after the cytokine injection and did not recover. (b) The base of support
increased only initially. (c) Stride length measurements did not change
significantly.
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170166
analysis includes aspects of locomotion which are not
covered by the EAE score.
Comparing the footprints of different time points led
to the following additional observation. At baseline
evaluation, the animals delivered proper prints, putting
down their entire foot. However, after the onset of the
disease, the animals started to tiptoe slightly so that their
heel was not visible any more on the prints. This
tiptoeing behavior did not cease over the time course
and was still observed at D28. In animals, which under-
went sensitization but then received an injection of PBS
only without cytokines, tiptoeing could not be observed.
Fig. 6 shows baseline footprints and footprints from the
time points D7 and D28 from the same animal to
illustrate the tiptoeing. Additionally, the footprints of a
control animal (sensitization followed by PBS injection)
from the time point D7 are shown to demonstrate that
this animal did not tiptoe.
4. Discussion
The recently introduced targeted EAE model leads to
anatomically well localized, defined inflammatory lesions
and to reproducible functional deficits (Kerschensteiner et
al., 2004). In the present study, we applied a range of
established behavioral tests for hindlimb locomotion to the
localized EAE model with a lesion targeted to the dorsal
funiculus at a level of T8. Our data show that the targeted
EAE lesion did not substantially influence the spontaneous
exploratory and locomotor activity. On the other hand, the
basic hindlimb locomotor function, as well as more specific
aspects such as precision movements, balance and foot
exorotation, was affected to various degrees. The use of
specific behavioral tests enables us to quantify the affected
aspects of hindlimb locomotion and follow their recovery
over time in a much more precise way than by the
conventional EAE clinical score.
4.1. Spontaneous locomotor activity
Monitoring spontaneous locomotor activity is a strategy
widely used to quantify changes in overall activity. Activity
can be measured in various ways, e.g., the exploration of the
animals can be observed by eye (Metz et al., 2000), moni-
tored by video recordings (Castanon et al., 2001) or mea-
sured in activity-recording boxes (Ferguson and Cada, 2003;
Mikolajczak et al., 2002). Using the TSE ActiMot/MoTil
system, we found that the performance of the EAE animals
was not significantly different from that of the untreated
control group, with the exception of the number of rearings at
D3. At this time point, a significant decrease of rearings
could be observed, which completely recovered thereafter.
This deficit occurs most likely because many EAE animals
lose weight support at early stages of the disease and
therefore are not able to stand on their hind limbs.
In rodents with classical disseminated EAE, a significant
alteration in spontaneous behavior has been observed (Pol-
lak et al., 2000). This so called EAE-associated behavioral
syndrome results in reduced social exploration and de-
creased food intake. Symptoms appear before the onset of
the disease and vanish before the neurological symptoms
cease. Such sickness behavior has been reported in a wide
range of inflammatory and infectious diseases (Larson,
2002). Activation of the immune system leads to high levels
of proinflammatory cytokines which result in changes of
behavior and motivation. A decrease in the general activity
as seen during the sickness behavior would of course
interfere with the locomotor performance in specific tests
so that the neurological deficits would be overlaid by
systemic symptoms. Therefore, the locomotor abilities
would be underestimated.
For induction of targeted EAE, a subclinical stimulation
of the immune system is required. Our results indicate that
this immune stimulation is insufficient to cause the sickness
behavior typical for systemic EAE. In line with the activity
Fig. 6. Footprints of one EAE animal at three different time points (BL, D7, D28) and of one control animal at time point D7. During baseline measurements,
the EAE animal put down the entire foot. After the cytokine injection, the heel was not visible any more on the prints due to slight tip toeing. In the control
animal, which received an injection of PBS only after the sensitization procedure, such tiptoeing was not observed during the entire time course.
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170 167
data is the following observations: we controlled the body
weight of the animals every second day and we could
observe only a slight decrease in weight around the onset
of the disease, which was substantially less than the pro-
nounced weight loss seen in classical EAE models (data not
shown). These results indicate that in the targeted EAE
model, alterations of the locomotor activity due to EAE-
associated behavioral alterations are much less likely to
interfere with behavioral testing of motor function than in
conventional EAE models.
4.2. Basic locomotor tests
4.2.1. EAE clinical score
The 5-point EAE clinical score is a qualitative scoring
system widely used in the field of EAE to assess basic
locomotion (Kerschensteiner et al., 2004; Meyer et al.,
2001). Sensitization with MOG alone did not lead to any
clinical signs of disease. Three days after the injection of the
cytokines into the spinal cord, the animals developed
neurological impairments reflected by EAE scores of 1.5–
3. The scores returned to low baseline levels 3–4 weeks
later. A major advantage of the EAE scoring system is that it
can be performed relatively quickly and thus can be carried
out daily in order to provide a good overview over the entire
disease process. In addition, this scoring system is well
suited for the variable clinical symptoms typical for con-
ventional, disseminated EAE models. However, it provides
only a very imprecise read-out for the specific locomotor
abilities of the animals. We therefore consider it crucial to
refine these results by more specific and precise behavioral
tests.
4.2.2. BBB open field locomotion score
The BBB open field locomotion score measures hind-
limb use during over-ground locomotion. The animals
showed a pronounced deficit in the BBB score right after
the onset of the disease, which recovered in parallel with
the EAE score almost completely within the testing
period. Accordingly, EAE and BBB scores showed a
strong correlation over the entire time course of the
disease.
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170168
The BBB open field locomotion score has been devel-
oped to assess over-ground locomotion in rats with a
spinal cord contusion lesion (Basso et al., 1995). Over-
ground locomotion is influenced by various tract systems
of the dorsal, lateral and ventral columns of the spinal
cord (Loy et al., 2002; Muir and Webb, 2000; Schucht et
al., 2002). For normal coordinated stepping, it is essential
that local spinal pattern generating networks are activated
properly by descending tracts. The ventrally running
reticulospinal tract probably plays the most important role
in activating these networks (Grillner, 1996; Jordan,
1998). In agreement with our results, animals with a
surgical lesion restricted to the dorsal columns showed
an almost complete recovery of basic locomotor function
(Loy et al., 2002; Metz et al., 2000; Schucht et al., 2002).
In an earlier EAE study, we have shown that only animals
with a lesion extension well into the lateral and the ventral
part of the spinal cord showed a remaining BBB deficit
after 28 days (Kerschensteiner et al., 2004). Animals with
an EAE lesion restricted to the dorsal column recovered
fully.
One disadvantage of the BBB scale is that it is not linear.
In its lower rating range, it measures rather gross aspects of
locomotion, whereas in the upper range of the scale, the
focus is set on discrete aspects of fine movements. We found
that in the lower rating range, the locomotor features of our
EAE animals recovered according to the order on the
scale. In the upper rating range, however, some features
improved at earlier stages than described by the scale. This
observation has already been made previously by studies
applying the BBB score to a hemisection rather than a
contusion model of spinal cord injury in rats (Metz et al.,
2000). As suggested by this group, this problem can be
solved by adding points independently for single features
like tail position or toe clearance when they occur at an
earlier stage.
With this adaptation, we consider the BBB score a very
valuable test for EAE animals. The BBB scoring system
requires more time than the EAE scoring system but
delivers a more exact picture of an animal’s locomotor
status and recovery.
4.3. Tests for specific aspects of locomotion
4.3.1. Grid walk
The animals with a local EAE lesion targeted to the
dorsal column revealed a substantial deficit in the grid walk
performance at early time points (D3 and D7). The grid
walk paradigm assesses deficits in the descending fine
motor control. It requires voluntary fine movement control
which is predominantly mediated by the corticospinal tract,
as well as forelimb–hindlimb coordination mediated by
ventrolateral tracts, and a proper initiation of the stepping
rhythm controlled mainly by the reticulospinal system
(Kunkel-Bagden et al., 1993; Metz et al., 2000). Thus, the
test is more specific for measuring lesions in the dorsal
columns than a general test such as the EAE or BBB score.
In line with these findings, we have previously found a good
correlation between the persistent deficits in the grid walk
task and the damage to the corticospinal tract system in
animals with targeted EAE lesions (Kerschensteiner et al.,
2004). An important advantage of this test system is its
parametric nature and objectiveness which allows interla-
boratory comparisons.
In summary, the grid walk test provides a valuable option
for the evaluation of precise hindlimb placing and thus the
descending motor control in targeted EAE animals.
4.3.2. Narrow beam
The results obtained from the narrow beam test resemble
the grid walk results: animals showed a high deficit at D3,
and the pronounced recovery took place within the sequent
2 weeks. In contrast to the grid walk, also animals with a
high initial deficit can be tested on the beams.
Beam walk abilities rely on descending motor control of
the vestibulospinal tract and of the CST (Hicks and
D’Amato, 1975; Metz et al., 2000). Additionally, it has
been seen in cats that their performance on the narrow
beam was impaired after the transection of the supraspinal
control to the tail only (Walker et al., 1998), indicating that
the integrity of the tail function is crucial to fulfil the task.
At early stages of EAE and in some animals with more
severe disease also at later stages, the tail position and
function is hampered. Thus, we considered this test well
suited.
A special benefit of the test is that the use of beams with
different width and shape can alter the difficulty of the task.
With a wide rectangular beam, gross deficits in locomotor
control can be detected, whereas a round narrow beam
reveals deficits in balance and fine motor control which
would be missed if one looked only at general over-ground
locomotion. Due to the variable levels of difficulty, the time
window in which animals can be tested on the narrow beam
is much wider than in the grid walk paradigm, making it
particularly suitable for testing animals with severe motor
deficits.
Overall the narrow beam provides another valuable
option for the evaluation of balance, tail function and
descending motor control in animals with targeted EAE.
4.3.3. Footprint analysis
By analyzing the footprints of an animal, one can obtain
information about the angle of foot rotation, base of support,
stride length, balance and limb movement kinetics (Kunkel-
Bagden et al., 1993; Metz et al., 2000).
The EAE lesions targeted to the dorsal columns caused
an increased exorotation of the hindfeet, which did not
recover. This is interesting to note as the vast majority of
other behavioral parameters undergo an extensive recovery
process during the study period. Measurements of the
exorotation of the hindfeet are therefore of high value for
the assessment of long-term deficits caused by EAE. Exor-
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170 169
otation of the hindfeet indicates that the animal tries to
compensate balance problems, which reflect CST or
descending pathway lesions.
Mean values of the base of support also increased initially.
By D14, the mean values of the base of support were,
however, below the baseline, and individual measurements
showed a high variability even in the baseline measurements.
This uneven walking pattern is likely to again reflect balance
problems caused by the EAE lesion.
The tiptoeing, which we were able to observe after the
disease onset, has been reported before in animals with a
demyelinated ventrolateral funiculus leading to a conduc-
tion block in the affected tract system (Loy et al., 2002). At
least in some cases, our lesion did expand along the
meninges into the ventrolateral region of the spinal cord.
It could be that similar processes occurred in our animals as
seen by Loy et al. (2002). Another cause for the tiptoeing
could come directly from the CST or descending pathway
lesions.
In summary, it can be concluded that the footprint
measurements are the only parameters which show no
significant recovery. In addition, footprint analysis is the
only test which does not correlate with the EAE score,
indicating that it addresses different aspects of locomotion
then the other tests.
4.4. Comparison with the traumatic spinal cord injury
model
The major difference between animals with a traumatic
spinal cord lesion and animals with a targeted EAE lesion
is the extent of functional recovery which is substantially
more pronounced in animals with a targeted EAE lesion.
In the traumatic spinal cord injury model, many axons of
the large tracts are transected mechanically, whereas in the
targeted EAE model, many axons lose their function only
temporarily due to the inflammatory milieu; cytokines,
edema and demyelination can cause a temporary conduc-
tion block. Redistribution of sodium channels as well as
remyelination assist these axons in regaining conduction
abilities. Thus, especially when the inflammation is mild,
the initial neurological deficits exceed the persistent def-
icit and the structural damage by far. This is underlined
by the remarkable improvement in the locomotor behavior
which took place within 2–3 weeks after lesion induction
in animals with targeted EAE. This pronounced recovery
indicates that the impairment at early stages can be
mainly attributed to the axonal dysfunction caused by
inflammation. The loss of smaller numbers of axons in a
given tract can also be compensated well by the remain-
ing fibers, at least for relatively global functions. Only
those EAE animals with a substantial amount of structural
damage are bound to develop persistent deficits. In
contrast, animals with a partly transected or contused
spinal cord recover more slowly and to a lesser degree
(Metz et al., 2000).
Regardless of this difference in pathophysiology, our
results show that many of the tests used in the field of spinal
cord injury can be transferred to the targeted EAE model.
4.5. Testing strategy
One of our aims was to establish a testing strategy for the
targeted EAE model which would be refined and sensitive
enough to detect even small improvements occurring spon-
taneously or as a result of therapeutic interventions. We
consider it crucial to combine several tests within one
experiment in order to obtain a broad assessment of the
sensorimotor recovery.
As a crude, fast and basic examination of locomotor
behavior, the broadly used EAE score is a useful tool.
Although imprecise, it is easy and fast to perform. The value
of the EAE scoring system is underlined by our findings that
many of themore specific tests correlated with the EAE score.
The EAE score can therefore be used as a common initial
screen. The results of which should then be refined by the use
of more precise and sensitive behavioral tests.
On a first level of priority, we suggest performing a BBB
score. Although the BBB score measures similar aspects as
the EAE score, it already provides a much more detailed
graduation of the over-ground locomotion deficits. Due to
the broad range of the scale, animals can be judged
adequately from very mild to very severe deficits.
On a second level, one or two further tests addressingmore
specific aspects of locomotor function should be chosen. The
grid walk task is best suited for animals with mild to moderate
deficits in hindlimb motor function (BBB>10), as animals
have to be able to perform weight-supported steps in order to
be analysed on the grid walk. The grid walk provides an
excellent, objective and reproducible way for quantifying
deficits in precise hindlimb placing. The narrow beam task
requires a subjective judgment and provides a less-precise
grading of the outcome parameter. However, it can be applied
in animals of all severity grades and is thus the test of choice
for animals with severe motor deficits. Footprint analysis
provide a parameter, the exorotation of the feet, which does
not recover over time and may thus be an interesting indicator
of permanent deficits.
In conclusion, many of the tests used to assess hindlimb
sensorimotor behavior in traumatic spinal cord injury mod-
els can be transferred reliably to a localized EAE model.
They allow monitoring in detail the functional deficits and
their recovery during the disease course of EAE. They
provide, therefore, a valuable tool for MS related therapeutic
interventions.
Acknowledgements
We wish to thank Eva Hochreutener and Roland Schob
for help with illustrations. We also thank Richard Klaghofer
for help with the statistics.
B.S. Buddeberg et al. / Journal of Neuroimmunology 153 (2004) 158–170170
References
Basso, D.M., Beattie, M.S., Bresnahan, J.C., 1995. A sensitive and reliable
locomotor rating scale for open field testing in rats. J. Neurotrauma 12,
1–21.
Castanon, N., Bluthe, R.M., Dantzer, R., 2001. Chronic treatment with the
atypical antidepressant tianeptin attenuates sickness behavior induced
by peripheral but not central lipopolysaccharide and interleukin-1beta in
the rat. Psychopharmacology 154, 50–60.
de Medinaceli, L., Freed, W.J., Wyatt, R.J., 1982. An index of the func-
tional condition of rat sciatic nerve based on measurements made from
walking tracks. Exp. Neurol. 77, 634–643.
Ferguson, S.A., Cada, A.M., 2003. A longitudinal study of short- and long-
term activity levels in male and female spontaneously hypertensive,
Wistar–Kyoto, Sprague–Dawley rats. Behav. Neurosci. 117, 271–282.
Grillner, S., 1996. Neural networks for vertebrate locomotion. Sci. Am.
274, 64–69.
Hicks, S.P., D’Amato, C.J., 1975. Motor – sensory cortex–corticospinal
system and developing locomotion and placing in rats. Am. J. Anat.
143, 1–42.
Jordan, L.M., 1998. Initiation of locomotion in mammals. Ann. N.Y. Acad.
Sci. 860, 83–93.
Kerschensteiner, M., Stadelmann, C., Buddeberg, B.S., Merkler, D.,
Bareyre, F.M., Anthony, D.C., Linington, C., Bruck, W., Schwab,
M.E., 2004. Targeting EAE lesions to a predetermined axonal tract
system allows for refined behavioral testing in an animal model of
multiple sclerosis. Am. J. Pathol. 164, 1455–1469.
Kunkel-Bagden, E., Hai-Ning, D., Bregman, B.S., 1993. Methods to assess
the development and recovery of locomotor function after spinal cord
injury in rats. Exp. Neurol. 119, 153–164.
Larson, S.J., 2002. Behavioral and motivational effects of immune-system
activation. J. Gen. Psych. 129, 401–414.
Loy, D.N., Talbott, J.F., Onifer, S.M., Mills, M.D., Burke, D.A., Dennison,
J.B., Fajardo, L.C., Magnuson, D.S.K., Whittemore, S.R., 2002. Both
dorsal and ventral spinal cord pathways contribute to overground loco-
motion in the adult rat. Exp. Neurol. 177, 575–580.
Merkler, D., Metz, G.A.S., Raineteau, O., Dietz, V., Schwab, M.E., Fouad,
K., 2001. Locomotor recovery in spinal cord-injured rats treated with an
antibody neutralizing the myelin-associated neurite growth inhibitor
nogo-A. J. Neurosci. 21, 3665–3673.
Metz, G.A.S., Whishaw, I.Q., 2002. Cortical and subcortical lesions impair
skilled walking in the ladder rung walking test: a new task to evaluate
fore- and hindlimb stepping, placing, and co-ordination. J. Neurosci.
Methods 115, 169–179.
Metz, G.A.S., Merkler, D., Dietz, V., Schwab, M.E., Fouad, K., 2000.
Efficient testing of motor function in spinal cord injured rats. Brain
Res. 883, 165–177.
Meyer, R., Weissert, R., Diem, R., Storch, M.K., de Graaf, K.L., Kramer,
B., Bahr, M., 2001. Acute neuronal apoptosis in a rat model of multiple
sclerosis. J. Neurosci. 21, 6214–6220.
Mikolajczak, P., Okulicz-Kozaryn, I., Kaminska, E., Niedopad, L.,
Polanska, A., Gebka, J., 2002. Effects of acamprosate and some
polyamine site ligands of NMDA receptor on short-term memory
in rats. Eur. J. Pharmacol. 444, 83–86.
Muir, G.D., Webb, A.A., 2000. Assessment of behavioral recovery follow-
ing spinal cord injury in rats. Eur. J. Neurosci. 12, 3079–3086.
Noseworthy, J.H., Luchhinetti, C., Rodriguez, M., Weinshenker, B.G.,
2000. Multiple Sclerosis. N. Engl. J. Med. 343, 938–952.
Pearson, K., 1976. The control of walking. Sci Am 235, 72–74, 79–82,
83–86.
Pollak, Y., Ovadia, H., Goshen, I., Gurevich, R., Monsa, K., Avitsur, R.,
Yirmiya, R., 2000. Behavioral aspects of experimental autoimmune
encephalomyelitis. J. Neuroimmunol. 104, 31–36.
Pollak, Y., Ovadia, H., Orion, E., Weidenfeld, J., Yirmiya, R., 2003a. The
EAE-associated behavioral syndrome: I. Temporal correlation with in-
flammatory mediators. J. Neuroimmunol. 137, 94–99.
Pollak, Y., Ovadia, H., Orion, E., Yirmiya, R., 2003b. The EAE-associated
behavioral syndrome: II. Modulation by anti-inflammatory treatments.
J. Neuroimmunol. 137, 100–108.
Raineteau, O., Schwab, M.E., 2001. Plasticity of motor systems after in-
complete spinal cord injury. Nat. Rev. Neurosci. 2, 263–273.
Schucht, P., Raineteau, O., Schwab, M.E., Fouad, K., 2002. Anatomical
correlates of locomotor recovery following dorsal and ventral lesions of
the rat spinal cord. Exp. Neurol. 176, 143–153.
Walker, C., Vierck Jr., C.J., Ritz, L.A., 1998. Balance in the cat: role of
the tail and effects of sacrocaudal transection. Behav. Brain Res. 91,
41–47.